40 completed. 40 Phase 2, 5 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 40 | Completed 40 |
| Phase 1 | 5 | Completed 5 |
| Phase 3 | 2 | Completed 2 |
Follow Rosacea: new trials by email Literature Review of Rosacea trials Research Report on Rosacea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea KTP laser, Ivermectin 1% cream - Rosacea | Phase 2 | Completed | Insel Gruppe AG, University Hospital Bern | 22 | 2023-09-12 | 2024-12-06 |
| Study of TP-04 in Participants With Papulopustular Rosacea Lotilaner Gel, 2.0%, Vehicle control gel - Papulopustular Rosacea | Phase 2 | Completed | Tarsus Pharmaceuticals, Inc. | 37 | 2023-03-01 | 2023-11-24 |
| Evaluation of the Safety and Efficacy of Topical Roflumilast Cream in the Treatment of Facial Papulopustular Rosacea Roflumilast Cream - Rosacea | Phase 2 | Completed | Dermatology Consulting Services, PLLC | 40 | 2022-04-15 | 2023-05-31 |
| Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea Rifaximin, Placebo - Papulopustular Rosacea | Phase 2 | Completed | Alfasigma S.p.A. | 216 | 2021-10-05 | 2024-04-24 |
| Therapeutic Effects of Topical Herbal Medicine -Rhubarb Ointment on Rosacea dian dao san - Rosacea, Chinese Herbal Medicine | Phase 2 | Completed | Chang Gung Memorial Hospital | 24 | 2021-08-04 | 2025-04-01 |
| CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea CGB-400, Vehicle Gel - Rosacea | Phase 2 | Completed | CAGE Bio Inc. | 78 | 2021-05-07 | 2026-04-01 |
| Rosacea and Ivermectin ivermectin, digital interaction, GPSkin - Rosacea | Phase 2 | Completed | Wake Forest University Health Sciences | 30 | 2021-04-16 | 2026-03-27 |
| A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea B244, Vehicle - Rosacea | Phase 2 | Completed | AOBiome LLC | 140 | 2018-07-02 | 2022-09-16 |
| Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea ACCU-D1, Vehicle - Acne Rosacea | Phase 2 | Completed | Accuitis, Inc. | 40 | 2017-11-28 | 2021-08-23 |
| Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea 1% Topical Minocycline Gel, 3% Topical Minocycline Gel, Topical Vehicle Gel - Rosacea, Papulopustular Rosacea | Phase 2 | Completed | Hovione Scientia Limited | 270 | 2017-10-30 | 2019-11-08 |
| A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules DFD-29 Extended Release Capsules (40 mg), DFD-29 Extended Release Capsules (20 mg), Oraycea® (doxycycline) Capsules - Rosacea | Phase 2 | Completed | Dr. Reddy's Laboratories Limited | 205 | 2017-10-01 | 2021-03-01 |
| Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea Secukinumab - Papulopustular Rosacea | Phase 1 / Phase 2 | Completed | Anne Chang | 24 | 2017-06-21 | 2020-02-05 |
| DMT210 Topical Gel in the Treatment of Acne Rosacea DMT210 Topical Gel 5%, Vehicle Control - Acne Rosacea | Phase 2 | Completed | Dermata Therapeutics | 107 | 2017-01-01 | 2018-04-18 |
| A Study to Assess the Efficacy, Safety and Tolerability of DFD-04 DFD-04 Ointment, Placebo Ointment - Rosacea | Phase 2 | Completed | Dr. Reddy's Laboratories Limited | 61 | 2016-07-01 | 2019-01-23 |
| Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation. Ivermectin - Rosacea | Phase 1 / Phase 2 | Completed | University of California, San Diego | 25 | 2016-07-01 | 2021-10-05 |
| Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea FMX-103 1.5%, FMX-103 3%, Vehicle foam (0%) - Rosacea, Papulopustular Rosacea | Phase 2 | Completed | Vyne Therapeutics Inc. | 233 | 2015-09-01 | 2017-02-15 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea PAC-14028 cream 0.1%, PAC-14028 cream 0.3%, PAC-14028 cream 1.0% - Rosacea | Phase 2 | Completed | Amorepacific Corporation | 216 | 2014-10-01 | 2016-09-20 |
| Effect of CD07805/47 Gel in Rosacea Flushing CD07805/47, CD07805/47+Placebo, Placebo, CD07805/47, Placebo, Placebo, CD07805/47+Placebo, CD07805/47, CD07805/47, Placebo, CD07805/47, CD07805/47+Placebo, Placebo, Placebo, CD07805/47 - Rosacea | Phase 2 | Completed | Galderma R&D | 34 | 2014-04-01 | 2016-10-20 |
| A Safety and Efficacy Study of DRM02 in Subjects With Rosacea DRM02, Vehicle - Rosacea | Phase 2 | Completed | Dermira, Inc. | 30 | 2013-10-01 | 2021-07-20 |
| An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema Cromolyn Sodium, Normal Saline - Papulopustular Rosacea | Phase 1 / Phase 2 | Completed | University of California, San Diego | 10 | 2013-08-01 | 2019-08-07 |
Showing 20 of 40. Sign in to see all of them.
Erythema (4) · Acne Vulgaris (2) · Skin Diseases (2) · Telangiectasis (2) · Corneal Neovascularization (1) · Dermatitis, Atopic (1) · Dermatitis, Seborrheic (1) · Flushing (1) · cyclopia sequence (1)
Skin and Connective Tissue Diseases (40) · Skin Diseases (38) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (4) · Skin Manifestations (4) · Acneiform Eruptions (2) · Cardiovascular Diseases (2) · Sebaceous Gland Diseases (2) · Vascular Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Corneal Diseases (1) · Dermatitis (1) · Eye Diseases (1) · Genetic Diseases, Inborn (1) · Hypersensitivity (1)
Ivermectin (3) · Gels (2) · azelaic acid (2) · Benchmarking (1) · Capsules (1) · Cromolyn Sodium (1) · Dapsone (1) · Doxycycline (1) · Lasers, Solid-State (1) · Metronidazole (1) · N-(1-(3,5-difluoro-4-methanesulfonylaminophenyl)ethyl)-3-(2-propyl-6-trifluoromethylpyridine-3-yl)acrylamide (1) · Ointments (1) · Omiganan (1) · Oxygen (1) · Rifaximin (1)
Galderma R&D (3) · Allergan (2) · Amorepacific Corporation (2) · Dr. Reddy's Laboratories Limited (2) · LEO Pharma (2) · University of California, San Diego (2) · AOBiome LLC (1) · Accuitis, Inc. (1) · Alfasigma S.p.A. (1) · Anne Chang (1) · Aria Aesthetics Inc. (1) · CAGE Bio Inc. (1) · Chang Gung Memorial Hospital (1) · Coria Laboratories, Ltd. (1) · DeNova Research (1)
United States (30) · Germany (4) · Canada (2) · South Korea (2) · Switzerland (1) · Taiwan (1)
Michael Graeber, MD (2) · Alan Fleischer, MD (1) · Alexa Kimball, MD, MPH (1) · Andrew Pollack, MD (1) · Angela Moore, MD (1) · Anne Chang, MD (1) · BeomJoon Kim, Professor (1) · Beth Zib (1) · Daniel M Stewart, DO (1) · Dow Stough, MD (1) · Eduardo Tschen, MD (1) · Fran Cook-Bolden, MD (1) · Gerald D Weinstein, MD (1) · Girish Munavalli, MD (1)
PMID 22395584, PMID 23233252, PMID 29396702, PMID 34076401, PMID 35096250, PMID 41778357